Pharmacy Times October 15, 2024
Anne Cassity

Legislative efforts in the states and Washington, DC, have made progress, but there is still a way to go.

For the past 15 years or so, independent pharmacy has been pushing consistently for transparency into the business practices of pharmacy benefit managers (PBMs) and reforms to their tactics. Patient steering, spread pricing, take-it-or-leave-it contracts, formulary manipulations, low or below-cost reimbursements, and other schemes have put tremendous pressure on independent pharmacies and patients seeking affordable, accessible care.

When it comes to finalizing reforms, we find ourselves at fourth-and-1. With the help of independent pharmacy team members, patients, and other allies, the ball has been moving ever closer to the goal line in Washington, DC.

Legislatively, the National Community Pharmacists Association (NCPA)...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
90% of independent pharmacies may not stock drugs in negotiation program: Study
The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights
Revolutionizing Pharma: The Power of AI and Chatbots in Clinical Trials and Beyond
Walgreens To Close 1,200 Stores, ‘Reorient’ Business Away From Health Care Services
Walgreens to close 1,200 stores

Share This Article